Mumbai, March 4 -- Gland Pharmahas received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application filed for Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC).

Published by HT Digital Content Services with permission from Capital Market....